Scinai Immunotherapeutics Ltd. SCNI
1.58 USD +0.03 (+1.66%)
Regular-session close
1.40 -0.18 -11.39%
After hours · Nov 20, 7:30 PM ET
1.45 Day range 1.70
1.13 52-week range 52.00
- YTD
- -94.45%
- 1 year
- -95.66%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.31M | 658.00K | 0 | 0 | 0 | |
| -2.65M | -580.00K | 0 | 0 | 0 | |
| -7.54M | -8.64M | -9.71M | -11.06M | -10.86M | |
| -8.31M | 4.80M | -6.50M | -5.80M | -8.21M |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.81M | 2.10M | 5.01M | 14.21M | 17.52M | |
| 11.63M | 13.45M | 17.47M | 27.07M | 32.04M | |
| 3.52M | 3.47M | 22.04M | 28.83M | 31.05M | |
| 2.27M | 2.09M | 20.56M | 21.54M | 28.98M | |
| 8.10M | 9.98M | -4.57M | -1.76M | 982.00K |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -6.03M | -6.33M | -9.38M | -7.26M | -7.43M | |
| -24.00K | -12.00K | -637.00K | -836.00K | -139.00K | |
| 5.77M | 3.44M | 1.09M | 6.78M | 21.43M | |
| -24.00K | -12.00K | -637.00K | -836.00K | -139.00K | |
| -284.00K | -2.92M | -9.21M | -3.30M | 14.44M |
